Skip to main
HTFL

HeartFlow Inc (HTFL) Stock Forecast & Price Target

HeartFlow Inc (HTFL) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 44%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

HeartFlow is well-positioned for continued growth and has delivered strong results with 2Q26 revenues of $64.1 million, a 48% increase compared to the previous year. The company's plaque business is rapidly ramping up with the positive 2026 reimbursement implementation, which has been highly synergistic with its core FFRCT business. HeartFlow's high gross margins, potential for further margin expansion, and potential upside to estimates from new reimbursement and account adds make it a strong investment opportunity. With a robust pipeline of clinical trials and a potential doubling of its TAM to $11 billion, HeartFlow is on track for durable mid-20s revenue growth in the years to come.

Bears say

HeartFlow is currently experiencing impressive growth with both the plaque and FFRCT components driving its revenue increase. However, the company's projected deceleration in the second half of 2026 and its conservative approach in terms of guidance suggest potential concerns about its future growth potential. Additionally, while its projected 2027 revenue shows strong growth, it may still be a conservative estimate considering the company's track record of underpromising and overdelivering. Therefore, while there may be some short-term risks and potential for slower growth in the future, HeartFlow remains a strong company with promising long-term prospects.

HeartFlow Inc (HTFL) has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 44% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartFlow Inc (HTFL) Forecast

Analysts have given HeartFlow Inc (HTFL) a Buy based on their latest research and market trends.

According to 9 analysts, HeartFlow Inc (HTFL) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartFlow Inc (HTFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.